Dr. Agarwal's Health Care: Fixation of Record Date w.r.t. the Scheme of Amalgamation between Dr. Agarwals Eye Hospital Limited and Dr.…
Dr. Agarwal's Health Care (AGARWALEYE) filed a disclosure titled "Fixation of Record Date w.r.t. the Scheme of Amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited, is disclosed". The company is valued at about ₹14,765…
What happened
Dr. Agarwal's Health Care (AGARWALEYE) filed a disclosure with the exchanges on 20 October 2026 at 07:12 PM titled "Fixation of Record Date w.r.t. the Scheme of Amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited, is disclosed".
Company snapshot
Dr. Agarwal's Health Care is a small-cap company in the Healthcare sector, with a market value of about ₹14,765 crore.
The stock last traded at ₹465.8, against a 52-week range of ₹401–₹567.8 (18.0% below the high).
Before this filing the shares had moved −7.8% over the month and −4.1% over three months. Average daily turnover over the last 20 sessions was about ₹12.94 crore.
Promoters held 32.34% at the end of Q1 FY27, down 0.02% points from the previous quarter. Foreign institutions owned 57.96% and domestic institutions 7.72%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 487 | 30.1 | 0.95 |
| Q2 FY26 | 499 | 29.7 | 0.94 |
| Q3 FY26 | 530 | 33.7 | 1.07 |
| Q4 FY26 | 564 | 39.7 | 1.25 |
| Q1 FY27 | 614 | 45.2 | 1.43 |
What history shows
This is not the company's first m&a disclosure: BCEIE has 5 earlier filings of this kind on record since May 2026.
After those filings, the stock fell 0.1% on average the next trading day and was down 2.9% on average after five days (2 filings with price data).
Across 138 similar disclosures by other Healthcare companies, shares moved +0.7% on average the next day and +1.1% over five days; 59% of them rose the next day.
Market-wide, 2,117 m&a filings with an impact score of 50 or more saw an average next-day move of +0.4%, with 49% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 5 Oct 2026 | Receipt of sanction from the Honble NCLT, Chennai Bench towards the… | −0.2% | −2.7% |
| 26 May 2026 | M&A | +0.1% | −3.2% |
What to watch
- Regulatory approvals, completion of the deal and its effect on revenue and margins.
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.